Polar Asset Management Partners Inc. Horizon Therapeutics Public LTD CO Transaction History

Polar Asset Management Partners Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $40.6 Million - $47.5 Million	-410,000 Reduced 92.13%	35,000 $4.05 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $20.7 Million - $24.2 Million	215,000 Added 93.48%	445,000 $45.8 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $5.9 Million - $6.24 Million	55,000 Added 31.43%	230,000 $25.1 Million
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $10.9 Million - $19.9 Million	175,000 New	175,000 $19.9 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.